Fresenius SE KGaA Past Earnings Performance
Past criteria checks 1/6
Fresenius SE KGaA's earnings have been declining at an average annual rate of -14.5%, while the Healthcare industry saw earnings growing at 4.4% annually. Revenues have been declining at an average rate of 1.4% per year. Fresenius SE KGaA's return on equity is 1.2%, and it has net margins of 1.6%.
Key information
-14.5%
Earnings growth rate
-14.7%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | -1.4% |
| Return on equity | 1.2% |
| Net Margin | 1.6% |
| Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?
Mar 29
Fresenius SE KGaA (ETR:FRE) Could Be At Risk Of Shrinking As A Company
Mar 13Why Fresenius SE & Co. KGaA (ETR:FRE) Could Be Worth Watching
Feb 06A Look At The Fair Value Of Fresenius SE & Co. KGaA (ETR:FRE)
Jan 19Fresenius SE & Co. KGaA's (ETR:FRE) Shares Not Telling The Full Story
Jan 03Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?
Nov 28Fresenius SE & Co. KGaA (ETR:FRE) Analysts Just Trimmed Their Revenue Forecasts By 34%
Nov 10Fresenius SE KGaA (ETR:FRE) Is Reinvesting At Lower Rates Of Return
Oct 27Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Sep 03Some Investors May Be Worried About Fresenius SE KGaA's (ETR:FRE) Returns On Capital
Jul 25We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt
Jun 19At €25.59, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?
Jun 01Capital Allocation Trends At Fresenius SE KGaA (ETR:FRE) Aren't Ideal
Apr 18Fresenius SE KGaA's (ETR:FRE) Soft Earnings Are Actually Better Than They Appear
Mar 13These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively
Mar 10Are Investors Undervaluing Fresenius SE & Co. KGaA (ETR:FRE) By 38%?
Feb 23Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Feb 08The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence
Jan 03These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively
Nov 28Should You Investigate Fresenius SE & Co. KGaA (ETR:FRE) At €21.71?
Oct 23The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence
Oct 01Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?
Aug 07Is It Time To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Jul 20Fresenius SE KGaA (ETR:FRE) May Have Issues Allocating Its Capital
Jul 02Fresenius SE KGaA (ETR:FRE) Is Increasing Its Dividend To €0.92
Apr 28At €34.09, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?
Apr 17Fresenius SE KGaA (ETR:FRE) Is Paying Out A Larger Dividend Than Last Year
Apr 02Fresenius SE KGaA (ETR:FRE) Could Be Struggling To Allocate Capital
Mar 27Fresenius SE KGaA's (ETR:FRE) Upcoming Dividend Will Be Larger Than Last Year's
Feb 24Is Now An Opportune Moment To Examine Fresenius SE & Co. KGaA (ETR:FRE)?
Jan 13Here's Why Fresenius SE KGaA (ETR:FRE) Has A Meaningful Debt Burden
Dec 29Fresenius SE KGaA (ETR:FRE) Could Be Struggling To Allocate Capital
Dec 14At €41.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?
Oct 15Is Fresenius SE KGaA (ETR:FRE) A Risky Investment?
Sep 30Fresenius SE KGaA (ETR:FRE) Is Reinvesting At Lower Rates Of Return
Sep 15Is Now The Time To Look At Buying Fresenius SE & Co. KGaA (ETR:FRE)?
Jul 17Fresenius SE KGaA (ETR:FRE) Takes On Some Risk With Its Use Of Debt
Jul 01There Are Reasons To Feel Uneasy About Fresenius SE KGaA's (ETR:FRE) Returns On Capital
Jun 14Should Shareholders Reconsider Fresenius SE & Co. KGaA's (ETR:FRE) CEO Compensation Package?
May 15Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Fresenius SE KGaA makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 22,299 | 353 | 3,155 | 608 |
| 30 Sep 23 | 41,599 | 941 | 6,916 | 875 |
| 30 Jun 23 | 41,467 | 1,026 | 6,941 | 853 |
| 31 Mar 23 | 41,345 | 1,305 | 6,877 | 861 |
| 31 Dec 22 | 21,532 | 1,154 | 3,094 | 614 |
| 30 Sep 22 | 25,828 | 1,444 | 3,561 | 610 |
| 30 Jun 22 | 29,766 | 1,611 | 4,080 | 677 |
| 31 Mar 22 | 38,256 | 1,796 | 5,580 | 777 |
| 31 Dec 21 | 37,520 | 1,818 | 5,453 | 784 |
| 30 Sep 21 | 36,858 | 1,729 | 5,423 | 800 |
| 30 Jun 21 | 36,452 | 1,743 | 5,341 | 757 |
| 31 Mar 21 | 36,126 | 1,683 | 5,149 | 758 |
| 31 Dec 20 | 36,277 | 1,707 | 5,235 | 758 |
| 30 Sep 20 | 36,284 | 1,812 | 5,378 | 741 |
| 30 Jun 20 | 36,208 | 1,829 | 5,418 | 752 |
| 31 Mar 20 | 36,049 | 1,889 | 5,517 | 698 |
| 31 Dec 19 | 35,409 | 1,883 | 5,406 | 660 |
| 30 Sep 19 | 34,933 | 1,884 | 5,159 | 644 |
| 30 Jun 19 | 34,283 | 1,859 | 5,105 | 613 |
| 31 Mar 19 | 33,904 | 2,040 | 4,991 | 635 |
| 31 Dec 18 | 33,530 | 2,027 | 4,893 | 646 |
| 30 Sep 18 | 33,390 | 2,022 | 5,136 | 660 |
| 30 Jun 18 | 33,495 | 1,999 | 5,177 | 640 |
| 31 Mar 18 | 33,645 | 1,797 | 5,341 | 596 |
| 31 Dec 17 | 33,886 | 1,814 | 5,554 | 558 |
| 30 Sep 17 | 33,011 | 1,745 | 5,192 | 524 |
| 30 Jun 17 | 32,147 | 1,731 | 5,143 | 513 |
| 31 Mar 17 | 30,818 | 1,659 | 4,933 | 508 |
| 31 Dec 16 | 29,471 | 1,560 | 4,742 | 502 |
| 30 Sep 16 | 28,908 | 1,477 | 4,620 | 480 |
| 30 Jun 16 | 28,415 | 1,452 | 4,489 | 473 |
| 31 Mar 16 | 28,158 | 1,399 | 4,413 | 473 |
| 31 Dec 15 | 27,626 | 1,358 | 4,195 | 464 |
| 30 Sep 15 | 26,889 | 1,256 | 4,031 | 443 |
| 30 Jun 15 | 25,927 | 1,175 | 3,832 | 422 |
| 31 Mar 15 | 24,502 | 1,136 | 3,533 | 394 |
| 31 Dec 14 | 23,231 | 1,067 | 3,359 | 369 |
| 30 Sep 14 | 22,010 | 1,094 | 3,170 | 359 |
| 30 Jun 14 | 21,077 | 1,083 | 3,057 | 351 |
| 31 Mar 14 | 20,653 | 1,040 | 3,055 | 352 |
| 31 Dec 13 | 20,331 | 1,011 | 3,044 | 348 |
| 30 Sep 13 | 20,440 | 974 | 3,325 | 341 |
| 30 Jun 13 | 20,259 | 952 | 3,293 | 330 |
Quality Earnings: FRE has high quality earnings.
Growing Profit Margin: FRE's current net profit margins (1.6%) are lower than last year (5.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FRE's earnings have declined by 14.5% per year over the past 5 years.
Accelerating Growth: FRE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: FRE had negative earnings growth (-69.4%) over the past year, making it difficult to compare to the Healthcare industry average (-7.5%).
Return on Equity
High ROE: FRE's Return on Equity (1.2%) is considered low.